Skip to main content

Dr. Lam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lam's full profile

Already have an account?

  • Office

    2700 Stockton Blvd
    Sacramento, CA 95817
    Phone+1 916-734-0910
    Fax+1 916-734-7946

Education & Training

  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1987 - 1989
  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1984 - 1987
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2021

Publications & Presentations

PubMed

Press Mentions

  • New Center for Experimental Therapeutics in Cancer Advances Promising Treatments
    New Center for Experimental Therapeutics in Cancer Advances Promising TreatmentsOctober 7th, 2022
  • Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis
    Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide SynthesisMarch 26th, 2024

Grant Support

  • Discovery Of Ligands For Directed-Differentiation Of Stem CellsNational Heart, Lung, And Blood Institute2012
  • Multi-Functional Nanocarrier Against Canine LymphomaNational Institute Of Biomedical Imaging And Bioengineering2011–2012
  • Therapeutic Targeting Agents For Ovarian CancerNational Cancer Institute2005–2012
  • High Affinity Capturing Agents For StrychnineNational Institute Of Neurological Disorders And Stroke2010–2011
  • Feasibility Of Nanoparticle-Mediated Paclitaxel DeliveryNational Center For Research Resources2010–2011
  • Dna-Modulated Release Of Drug From Melanoma Targeting NPNational Cancer Institute2008–2009
  • Optimization And Characterization Of Targeting Agents For Lymphoid MalignanciesNational Cancer Institute2007–2009
  • High Affinity Ligand To Deliver Nanoparticle Drugs To Lymphoid CancersNational Cancer Institute2007–2009
  • Targeting Agents For Human And Canine LymphomaNational Cancer Institute2005–2009
  • C-SRC Inhibitors From Novel Encoded Chemical LibrariesNational Cancer Institute2003–2007
  • Optimization And Characterization Of Targeting AgentsNational Cancer Institute2005–2006
  • Combinatorial Peptide Libraries For Biodegradable Linkers To Decrease Normal TissNational Cancer Institute2004–2006
  • Administrative CoreNational Cancer Institute2005
  • Protein Kinase Specific PET Imaging Agent For CancerNational Cancer Institute2004–2005
  • Small Molecule Microarrays For Intracellular ProteinsNational Cancer Institute2003–2005
  • UC Davis AP4 CenterNational Cancer Institute2004
  • Peptide Microarray For Cancer Cell Surface ReceptorsNational Institute Of Biomedical Imaging And Bioengineering2003
  • Peptide Microarray For Cancer Cell Surface ReceptorsNational Cancer Institute2001–2002
  • Ligands For Altered Phosphoproteins In CancerNational Cancer Institute2000–2002
  • Peptide Substrate For Unique Protein Kinase In TissueNational Cancer Institute1999–2000
  • Novel Antibiotics For Vancomycin Resistant InfectionNational Institute Of Allergy And Infectious Diseases1999
  • Peptide Ligand For Altered Protein In Disease TissuesNational Cancer Institute1999
  • Identification Of Small Molecule Inhibitors Of Protein Tyrosine KinaseNational Center For Research Resources1998–1999
  • Peptide Substrate For Unique Protein Kinase In TissueNational Cancer Institute1998
  • Peptide Ligand For Altered Protein In Disease TissuesNational Cancer Institute1998
  • Novel Antibiotics For Vancomycin Resistant InfectionNational Institute Of Allergy And Infectious Diseases1997–1998
  • Molecular Screening Of Cancer-Associated ReceptorsNational Cancer Institute1992–1994